NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/12/2023
Back to search
Official data from USPTO
MEDPRO COMPLIANCE ADVISORY SERVICES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MEDPRO COMPLIANCE ADVISORY SERVICES
ST13
US500000097310307Class
35, 41, 45
Filing
97310307
Registration
7160611
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
09/12/2023
Trademark type
Word
Nice classes
35, 41, 45
Filing date
03/14/2022
Registration date
09/12/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/12/2023
Last transaction
09/12/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/01/2021
First use in commerce
04/01/2021
Drawing code
4
Owner type
16
Owner location
Mt. Arlington, NJ, US
Examiner
RADEMACHER, APRIL LUEDERS
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MedPro Systems LLC
Representatives
Christine Amara SHERMAN ATLAS SYLVESTER & STAMELMAN LLP
Technical classification
Nice Classes
Class 35Class 41Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting services for life sciencespharmaceuticalsbiotechnology and medical device companies in the nature of regulatory compliance program development and enhancement and transparency program supportreviewing program status and performing gap analysesdrafting programs plansprogram implementation supportdevelopment and improvement of policiesstandard operating procedures and codes of conduct; business consulting services in the nature of monitoring of pharmaceutical and medical device manufacturer interactions with healthcare professionalshealthcare organizationspatientsother customers; business consulting services in the nature of auditing of pharmaceutical and medical device manufacturer interactions with and payments to healthcare professionalshealthcare organizationspatientsother customers; business consulting services in the nature of business investigation support for internally and externally raised complaints made against a pharmaceutical or medical device manufacturer related to potential violations of their company policy or codeindustry codelaw or regulation; transparency reporting regulatory submission managementassisting others in preparing and filing regulatory submissions in the field of transparency reporting for pharmaceuticalbiotechnology and medical device companies; business consulting servicestracking and monitoring regulatory requirements for others in the field of life sciencespharmaceuticalsbiotechnologymedical devices for regulatory compliance; business consulting servicescompliance program gap analysis for life sciencespharmaceuticalbiotechnologymedical device companies
Class 41
consulting services in the nature of conducting trainings for life sciencespharmaceuticalsbiotechnologymedical device companies personnel and partners on pharmaceutical and medical device compliance program requirementsfraud and corruption laws and regulationsindustry codes and best practices; consulting servicesdeveloping and providing trainings for life sciencespharmaceuticalbiotechnologymedical device companies in the field of corporate compliance and transparency programs
Class 45
Regulatory compliance consulting in the field of life sciencespharmaceuticalsbiotechnologymedical devices; consulting services to assist life sciencespharmaceuticalbiotechnology and medical device companies in the fields of regulatory compliancecompliance in the areas of aggregate spend disclosure reportingthe Prescription Drug Marketing Actthe Drug Supply Chain Security ActCondition of Participation for Outpatient ServicesStark Law and Ohio Terminal Distributor of Dangerous Drugs requirements; compliance audits in the field of life sciencespharmaceuticalbiotechnology and medical device companies regulatory compliance; consulting services in the field of life sciencespharmaceuticalbiotechnology and medical device corporate compliance program and transparency program developmentimplementation and support; regulatory compliance consultingreviewingdevelopingtraining on and assisting with the implementation and monitoring of standardspracticesprocedures and policies to support regulatory compliance for companies in the fields of life sciencespharmaceuticalsbiotechnologymedical devices
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/27/2023
PUBO
PUBLISHED FOR OPPOSITION
06/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/07/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/22/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/04/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/14/2023
GNRT
NON-FINAL ACTION E-MAILED
01/14/2023
CNRT
NON-FINAL ACTION WRITTEN
01/14/2023
DOCK
ASSIGNED TO EXAMINER
12/24/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/17/2022
NWAP
NEW APPLICATION ENTERED
03/17/2022
Continuous trademark protection
Get notified about every new filing that threatens MEDPRO COMPLIANCE ADVISORY SERVICES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.